A sub-utilização dos opióides na dor oncológica

Authors

  • Ferraz Gonçalves Assistente Hospitalar de Medicina Interna Unidade de Cuidados Continuados, Instituto Português de Oncologia - Centro do Porto

Keywords:

opioids, morphine, oncologic pain

Abstract

Pain is a frequent problem with major injluence in the quality of life of oncologic patients. Opioids, specially morphine, have a main importance in pain treatment, but the secundary place it has in the tea­ ching of medicine, makes they are incorrectly used. Myths, popular among patients, about oncologic pain and analgesics, often makes them relutant in reporting pain and adhering treatment.

It is of utmost importance to prescribe opioids apropriatelly and discuss with patients the need of using them as well as their side effects, avoiding the injustifible suffering of many of those patients.

Downloads

Download data is not yet available.

References

Organisation rnoncliale ele la Santé. Traitement ele la douleur can­ céreuse et soins palliatifs. Gencve 1990.

RoennJH. Cleelancl CS. Gonin R. Hatfielcl AK. Pandaya KJ Physi­cian attitudes and practice in cancer pain rnanagement: A sur­vey from the Eastern Cooperative Oncology Group. Ann In­tern Med 1993:119:121-126.

Portcnoy RK. Cancer pain: Epidemiology anel syndromes. Cancer 1989,63:2298-2307.

Ventafrida V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation of the WHO rnethod for cancer pain relief. Cancer 1987;59:850-856.

Ortiz JS. Eficacia de la escalem analgésica ele la OMS en la unidade de cuidados paliativos. Medicina Paliativa 1994; 1:15-21.

Foley K. Controversies in cancer pain: Medical perspectives. Can­cer 1989: 63:2257-2265.

Levin D:--J. Cledand CS. Dar R. Public attitudes toward cancer pain. Cancer 1985; 56:2337- 2339.

Hill CS. The barriers to adequate pain management with opioid analgesics. Semin Oncol 1993;20 (Suppll ):1-5.

lnturrisi CE. Management of cancer pain: Pharmacology anel prin­ciples of management. Cancer 1989:63:2308-2320.

Porter J, Jick H. Aclcliction rare in patients treated with narcotics. N Engl J Med 1980;302:123.

Warlield CA. Guidelines for routine use of controlled-release omlor­phine sulfate tablet . Semin Oncol 1993; 20 (Suppl 1 ): 36--t7.

Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. Engl J Med 1994; 330 651-655.

Hanks GW, Twycross RG. Pain. the physiological antagonist of opioid analgesics. Lancet 1984: i: 1477-1478.

Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid res­ponsiveness and its implications for neuropathic pain: :--Jew hypotheses derived from studies of opioid infusions. Pain 1990: 43:273-286.

Hanks GW, Justins DM. Cancer pain Mangement. Lancet 1992;3391031-1036.

Salamagne MH. Le traiment ele la douleur cancéreuse chronic. Revue Praticien 1993: 7: 21-29

Additional Files

Published

1995-03-31

How to Cite

1.
Gonçalves F. A sub-utilização dos opióides na dor oncológica. RPMI [Internet]. 1995 Mar. 31 [cited 2024 Nov. 23];2(1):40-3. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2344

Issue

Vol. 2 No. 1 (1995): Janeiro/ Março

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access